About 93% of people classified as low risk by the genetic test had no cancer in their lymph nodes, researchers recently reported in JAMA Surgery. These folks — representing more than a third of all ...

What was once a three-team race between the Bills, Chiefs and Ravens is now complicated, with several upstarts jumping into ...

a TV show that showcased extraordinary facts about remarkable people ... Fyodor Gabay Gabriel Baius Balahad Garin Garnier Gaspar Gaudfridus Gauvin Gawain Gene Geoffrey George Gerald Gerallt Gerard ...

A newly developed mouse model enables real-time visualization of RNA Polymerase II (RNAP2) during DNA transcription, as ...

Scientists at St. Jude Children's Research Hospital and Northwestern University identified a previously unknown treatment ...

Genetic engineers can design and assemble sophisticated gene circuits to program cells with new functions, but important ...

Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. Such "gene-switch" tools allow scientists to "turn on" ...

Steve Merlin works with fellow pancreatic cancer patients, telling his remarkable story of surviving 13 years since his diagnosis.

A Washington man appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has eluded the common dementia for decades. Researchers at the Washington University School ...

Results from the largest cohort of children who received a gene therapy for a rare immunodeficiency condition have shown the long-term safety and efficacy of the curative treatment, in a study led by ...

Neuronal ceroid lipofuscinosis type 1 (CLN1) disease, also known as infantile neuronal ceroid lipofuscinosis, is a rare and fatal neurodegenerative condition. CLN1 disease is caused by a deficiency in ...

An investigational gene therapy showed sustained clinical efficacy for children born with ADA-SCID. In a study of 62 children, overall survival after treatment was 100% and event-free survival was 95% ...